Supplemental
Interest Paid
Medline, Inc. Interest Paid decreased by 55.1% to $61.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 55.1%, from $136.00M to $61.00M. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementCash Flow Statement
SectionSupplemental
CategoryLeverage
SignalLower is better
VolatilityStable
First reportedQ4 2016
Last reportedQ3 2025
How to read this metric
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
Detailed definition
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Peer comparison
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
Metric ID:
interest_paidHistorical Data
10 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $281.50M | $281.50M | $281.50M | $281.50M | $255.50M | $255.50M | $255.50M | $255.50M | $136.00M | $61.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -9.2% | +0.0% | +0.0% | +0.0% | -46.8% | -55.1% |
| YoY Change | — | — | — | — | -9.2% | -9.2% | -9.2% | -9.2% | -46.8% | -55.1% |
Range$61.00M – $281.50M
CAGR-49.3%
Avg YoY Growth-23.1%
Median YoY Growth-9.2%
Current Streak2 quarters decline
Interest Paid at Other Companies
Frequently Asked Questions
- What is Medline, Inc. 's interest paid?
- Medline, Inc. (MDLN) reported interest paid of $61.00M in Q1 2026.
- How has Medline, Inc. 's interest paid changed year-over-year?
- Medline, Inc. 's interest paid decreased by 55.1% year-over-year, from $136.00M to $61.00M.
- What does interest paid mean?
- The actual cash paid to lenders for interest on debt.